US Patent Issued to SK BIOPHARMACEUTICALS on Nov. 11 for "Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,591, issued on Nov. 11, was assigned to SK BIOPHARMACEUTICALS Co. LTD. (Gyeonggi-Do, South Korea).

"Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy" was invented by Sun Gwan Hwang (Gyeonggi-do, South Korea) and Ji Won Lee (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to use of a carbamate compound of Formula 2 for the purpose of preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy by administering a pharmaceutical composition comprising a ca...